238 related articles for article (PubMed ID: 11603414)
1. Human immunoglobulin and the Guillain-Barre syndrome: new indication. An alternative to plasmapheresis.
Prescrire Int; 2000 Oct; 9(49):142-3. PubMed ID: 11603414
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA
Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755
[TBL] [Abstract][Full Text] [Related]
3. Adverse effect of polyvalent immunoglobulin in the treatment of Guillain-Barre syndrome.
Chamouni P; Tamion F; Gueit I; Girault C; Lenain P; Varin R; Czernichow P
Transfus Apher Sci; 2003 Apr; 28(2):117-24. PubMed ID: 12679114
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin and Guillain-Barré syndrome.
Harel M; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):281-7. PubMed ID: 16391403
[TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré syndrome in the elderly: clinical, electrophysiological, therapeutic and outcome features.
França MC; Deus-Silva L; de Castro R; Garibaldi SG; Pfeilsticker BH; Nucci A; Marques JF
Arq Neuropsiquiatr; 2005 Sep; 63(3B):772-5. PubMed ID: 16258654
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K
Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
[TBL] [Abstract][Full Text] [Related]
7. [Intravenous immunoglobulin therapy for Guillain-Barré syndrome in Japan: changes in treatment after its inclusion in health insurance coverage].
Nishimoto Y; Yuki N
Rinsho Shinkeigaku; 2004 Sep; 44(9):633-5. PubMed ID: 15515710
[TBL] [Abstract][Full Text] [Related]
8. Human Immunoglobulin Versus Plasmapheresis in Guillain-Barre Syndrome and Myasthenia Gravis: A Meta-Analysis.
Ortiz-Salas P; Velez-Van-Meerbeke A; Galvis-Gomez CA; Rodriguez Q JH
J Clin Neuromuscul Dis; 2016 Sep; 18(1):1-11. PubMed ID: 27552383
[TBL] [Abstract][Full Text] [Related]
9. Long-term prognosis for Guillain-Barré syndrome: evaluation of prognostic factors and clinical experience of automated double filtration plasmapheresis.
Cheng BC; Chang WN; Chen JB; Chee EC; Huang CR; Lu CH; Chang CJ; Hung PL; Chuang YC; Lee CT; Lee PY; Wang KW; Chang HW
J Clin Apher; 2003; 18(4):175-80. PubMed ID: 14699593
[TBL] [Abstract][Full Text] [Related]
10. [The effect of plasmapheresis and other immunomodulating therapies on the course of severe Guillain-Barré syndrome].
Hidasi E; Soltész P
Orv Hetil; 2001 Feb; 142(7):335-9. PubMed ID: 11243015
[TBL] [Abstract][Full Text] [Related]
11. Functional recovery of untreated human immunodeficiency virus-associated Guillain-Barré syndrome: a case report.
Schreiber AL; Norbury JW; De Sousa EA
Ann Phys Rehabil Med; 2011 Nov; 54(8):519-24. PubMed ID: 22036304
[TBL] [Abstract][Full Text] [Related]
12. Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome.
Koichihara R; Hamano S; Yamashita S; Tanaka M
Pediatr Neurol; 2008 Aug; 39(2):123-5. PubMed ID: 18639758
[TBL] [Abstract][Full Text] [Related]
13. Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over IVIg in patients with axonal involvement.
Dada MA; Kaplan AA
Ther Apher Dial; 2004 Oct; 8(5):409-12. PubMed ID: 15663537
[TBL] [Abstract][Full Text] [Related]
14. [Guillain-Barré syndrome in kidney transplant].
García Alvarez T; García Herrera A; Mazuecos Blanca A; Lancho Novillo C
Nefrologia; 2010; 30(2):260-1. PubMed ID: 20393626
[No Abstract] [Full Text] [Related]
15. Intravenous immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial.
DiMario FJ
Pediatrics; 2005 Jul; 116(1):226-8. PubMed ID: 15995056
[No Abstract] [Full Text] [Related]
16. Recurrent Guillain-Barre syndrome as a complication of immune reconstitution in HIV.
Makela P; Howe L; Glover S; Ferguson I; Pinto A; Gompels M
J Infect; 2002 Jan; 44(1):47-9. PubMed ID: 11972420
[No Abstract] [Full Text] [Related]
17. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.
Alexander KJ; Alshubaili AF; Santhamoorthy P; Sharafuddin KM
Med Princ Pract; 2008; 17(5):422-4. PubMed ID: 18685286
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin as therapy for pediatric Guillain-Barré syndrome.
Abd-Allah SA; Jansen PW; Ashwal S; Perkin RM
J Child Neurol; 1997 Sep; 12(6):376-80. PubMed ID: 9309521
[TBL] [Abstract][Full Text] [Related]
19. Landry Guillian-Barre Strohl syndrome in pregnancy: use of high-dose intravenous immunoglobulin.
Seoud M; Naboulsi M; Khalil A; Sarouphim P; Azar G; Khalifeh R
Acta Obstet Gynecol Scand; 1999 Nov; 78(10):912-3. PubMed ID: 10577623
[No Abstract] [Full Text] [Related]
20. [Adverse effects of intravenous human polyvalent immunoglobulins].
Chapuis C; Guy N; Besson G
Rev Neurol (Paris); 2008 Sep; 164 Spec No 3():F203-10. PubMed ID: 18992580
[No Abstract] [Full Text] [Related]
[Next] [New Search]
